Association of antiviral drugs and their possible mechanisms with DRESS syndrome using data mining algorithms

Author:

Sharma Akash1,Roy Sweta2,Sharma Ruchika3,Kumar Anoop12

Affiliation:

1. Department of Clinical Research Delhi Pharmaceutical Sciences and Research University (DPSRU) New Delhi India

2. Department of Pharmacology Delhi Pharmaceutical Sciences and Research University (DPSRU) New Delhi India

3. Centre for Precision Medicine and Pharmacy Delhi Pharmaceutical Sciences and Research University (DPSRU) New Delhi India

Abstract

AbstractAntiviral drugs are not known for drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome. The current study aims is to find out the association of antiviral drugs and their possible mechanism with DRESS. Data mining algorithms such as proportional reporting ratio that is, PRR (≥2) with associated χ2 value (>4), reporting odds ratio that is, ROR (≥2) with 95% confidence interval and case count (≥3) were calculated to identify a possible signal. Further, molecular docking studies were conducted to check the interaction of selected antiviral drugs with possible targets. The potential signal of DRESS was found to be associated with abacavir, acyclovir, ganciclovir, lamivudine, lopinavir, nevirapine, ribavirin, ritonavir, and zidovudine among all selected antiviral drugs. Further, subgroup analysis has also shown a potential signal in different age groups and gender. The sensitivity analysis results have shown a decrease in the strength of the signal, however, there was no significant impact on the outcome except for acyclovir. The docking results have indicated the possible involvement of human leukocyte antigen (HLA)*B1502 and HLA*B5801. The positive signal of DRESS was found with selected antiviral drugs except for acyclovir.

Publisher

Wiley

Subject

Infectious Diseases,Virology

Reference27 articles.

1. Practical aspects of signal detection in pharmacovigilance. Accessed July 2 2022.https://cioms.ch/wp-content/uploads/2018/03/WG8-Signal-Detection.pdf

2. Serious Adverse Drug Reactions and Safety Signals in Children: A Nationwide Database Study

3. Disproportionality Analysis for Pharmacovigilance Signal Detection in Small Databases or Subsets: Recommendations for Limiting False-Positive Associations

4. Pharmacovigilance Guidance Material. Accessed June 25 2022.https://allaboutpharmacovigilance.org/

5. Center for Drug Evaluation and Research. FDA adverse event reporting system (FAERS) public dashboard. US Food and Drug Administration. 2021. Accessed June 25 2022.https://www.fda.gov/drugs/questions-and-answers-fdas-adverse-event-reporting-system-faers/fda-adverse-event-reporting-system-faers-public-dashboard

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3